951 - 960 of 7916 Results
Title
Year
- Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease2023OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 4
- Dementia prevention in memory clinics: recommendations from the European task force for brain health services2023RESTRICTEDTitle: Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesJournal Name: The Lancet Regional Health - EuropePublisher: Elsevier BVVol: 26Issue #:Start Page: 100576End Page: 100576Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.lanepe.2022.100576Best OA location URL: https://doi.org/10.1016/j.lanepe.2022.100576Citation Count: 41
- Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease2023OPENTitle: Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 3Start Page: 112231End Page: 112231Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2023.112231Best OA location URL: http://www.cell.com/article/S2211124723002425/pdfCitation Count: 20
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
- Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopy2023OPENTitle: Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopyJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 102024End Page: 102024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2022.102024Best OA location URL: https://doi.org/10.1016/j.xpro.2022.102024Citation Count: 5
- LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts2023OPENTitle: LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00468-2Best OA location URL: https://www.nature.com/articles/s41531-023-00468-2.pdfCitation Count: 10
-
OPENTitle: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 885End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29358Citation Count: 23
- Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's Disease2023RESTRICTEDTitle: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's DiseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.5281/zenodo.7679354Citation Count: 1
- Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older2023OPENTitle: Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and OlderJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 16Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000207077Best OA location URL: https://n.neurology.org/content/neurology/early/2023/02/27/WNL.0000000000207077.full.pdfCitation Count: 18
-
OPENTitle: A call for clinical trial globalization in Alzheimer's disease and related dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 7Start Page: 3210End Page: 3221Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12995Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12995Citation Count: 5